Morphologic and molecular characterization of renal cell carcinoma in children and young adults

Elisabeth Bruder, Oliver Passera, Dieter Harms, Ivo Leuschner, Marc Ladanyi, Pedram Argani, John Eble, Kirsten Struckmann, Peter Schraml, Holger Moch

Research output: Contribution to journalArticle

183 Citations (Scopus)

Abstract

A new WHO classification of renal cell carcinoma has been introduced in 2004. This classification includes the recently described renal cell carcinomas with the ASPL-TFE3 gene fusion and carcinomas with a PRCC-TFE3 gene fusion. Collectively, these tumors have been termed Xp11.2 or TFE3 translocation carcinomas, which primarily occur in children and young adults. To further study the characteristics of renal cell carcinoma in young patients and to determine their genetic background, 41 renal cell carcinomas of patients younger than 22 years were morphologically and genetically characterized. Loss of heterozygosity analysis of the von Hippel-Lindau gene region and screening for VHL gene mutations by direct sequencing were performed in 20 tumors. TFE3 protein overexpression, which correlates with the presence of a TFE3 gene fusion, was assessed by immunohistochemistry. Applying the new WHO classification for renal cell carcinoma, there were 6 clear cell (15%), 9 papillary (22%), 2 chromophobe, and 2 collecting duct carcinomas. Eight carcinomas showed translocation carcinoma morphology (20%). One carcinoma occurred 4 years after a neuroblastoma. Thirteen tumors could not be assigned to types specified by the new WHO classification: 10 were grouped as unclassified (24%), including a unique renal cell carcinoma with prominently vacuolated cytoplasm and WT1 expression. Three carcinomas occurred in combination with nephroblastoma. Molecular analysis revealed deletions at 3p25-26 in one translocation carcinoma, one chromophobe renal cell carcinoma, and one papillary renal cell carcinoma. There were no VHL mutations. Nuclear TFE3 overexpression was detected in 6 renal cell carcinomas, all of which showed areas with voluminous cytoplasm and foci of papillary architecture, consistent with a translocation carcinoma phenotype. The large proportion of TFE3 "translocation" carcinomas and "unclassified" carcinomas in the first two decades of life demonstrates that renal cell carcinomas in young patients contain genetically and phenotypically distinct tumors with further potential for novel renal cell carcinoma subtypes. The far lower frequency of clear cell carcinomas and VHL alterations compared with adults suggests that renal cell carcinomas in young patients have a unique genetic background.

Original languageEnglish
Pages (from-to)1117-1132
Number of pages16
JournalAmerican Journal of Surgical Pathology
Volume28
Issue number9
DOIs
StatePublished - Sep 2004

Fingerprint

Renal Cell Carcinoma
Young Adult
Carcinoma
Gene Fusion
Neoplasms
Cytoplasm
Mutation
Wilms Tumor
Loss of Heterozygosity
Neuroblastoma
Genes
Immunohistochemistry
Phenotype

Keywords

  • Microsatellite instability
  • Pediatric renal tumors
  • TFE3
  • Translocation carcinomas
  • VHL gene
  • Wilms tumor

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

Morphologic and molecular characterization of renal cell carcinoma in children and young adults. / Bruder, Elisabeth; Passera, Oliver; Harms, Dieter; Leuschner, Ivo; Ladanyi, Marc; Argani, Pedram; Eble, John; Struckmann, Kirsten; Schraml, Peter; Moch, Holger.

In: American Journal of Surgical Pathology, Vol. 28, No. 9, 09.2004, p. 1117-1132.

Research output: Contribution to journalArticle

Bruder, E, Passera, O, Harms, D, Leuschner, I, Ladanyi, M, Argani, P, Eble, J, Struckmann, K, Schraml, P & Moch, H 2004, 'Morphologic and molecular characterization of renal cell carcinoma in children and young adults', American Journal of Surgical Pathology, vol. 28, no. 9, pp. 1117-1132. https://doi.org/10.1097/01.pas.0000131558.32412.40
Bruder, Elisabeth ; Passera, Oliver ; Harms, Dieter ; Leuschner, Ivo ; Ladanyi, Marc ; Argani, Pedram ; Eble, John ; Struckmann, Kirsten ; Schraml, Peter ; Moch, Holger. / Morphologic and molecular characterization of renal cell carcinoma in children and young adults. In: American Journal of Surgical Pathology. 2004 ; Vol. 28, No. 9. pp. 1117-1132.
@article{c750457ae0be4c4c912cb67474861580,
title = "Morphologic and molecular characterization of renal cell carcinoma in children and young adults",
abstract = "A new WHO classification of renal cell carcinoma has been introduced in 2004. This classification includes the recently described renal cell carcinomas with the ASPL-TFE3 gene fusion and carcinomas with a PRCC-TFE3 gene fusion. Collectively, these tumors have been termed Xp11.2 or TFE3 translocation carcinomas, which primarily occur in children and young adults. To further study the characteristics of renal cell carcinoma in young patients and to determine their genetic background, 41 renal cell carcinomas of patients younger than 22 years were morphologically and genetically characterized. Loss of heterozygosity analysis of the von Hippel-Lindau gene region and screening for VHL gene mutations by direct sequencing were performed in 20 tumors. TFE3 protein overexpression, which correlates with the presence of a TFE3 gene fusion, was assessed by immunohistochemistry. Applying the new WHO classification for renal cell carcinoma, there were 6 clear cell (15{\%}), 9 papillary (22{\%}), 2 chromophobe, and 2 collecting duct carcinomas. Eight carcinomas showed translocation carcinoma morphology (20{\%}). One carcinoma occurred 4 years after a neuroblastoma. Thirteen tumors could not be assigned to types specified by the new WHO classification: 10 were grouped as unclassified (24{\%}), including a unique renal cell carcinoma with prominently vacuolated cytoplasm and WT1 expression. Three carcinomas occurred in combination with nephroblastoma. Molecular analysis revealed deletions at 3p25-26 in one translocation carcinoma, one chromophobe renal cell carcinoma, and one papillary renal cell carcinoma. There were no VHL mutations. Nuclear TFE3 overexpression was detected in 6 renal cell carcinomas, all of which showed areas with voluminous cytoplasm and foci of papillary architecture, consistent with a translocation carcinoma phenotype. The large proportion of TFE3 {"}translocation{"} carcinomas and {"}unclassified{"} carcinomas in the first two decades of life demonstrates that renal cell carcinomas in young patients contain genetically and phenotypically distinct tumors with further potential for novel renal cell carcinoma subtypes. The far lower frequency of clear cell carcinomas and VHL alterations compared with adults suggests that renal cell carcinomas in young patients have a unique genetic background.",
keywords = "Microsatellite instability, Pediatric renal tumors, TFE3, Translocation carcinomas, VHL gene, Wilms tumor",
author = "Elisabeth Bruder and Oliver Passera and Dieter Harms and Ivo Leuschner and Marc Ladanyi and Pedram Argani and John Eble and Kirsten Struckmann and Peter Schraml and Holger Moch",
year = "2004",
month = "9",
doi = "10.1097/01.pas.0000131558.32412.40",
language = "English",
volume = "28",
pages = "1117--1132",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Morphologic and molecular characterization of renal cell carcinoma in children and young adults

AU - Bruder, Elisabeth

AU - Passera, Oliver

AU - Harms, Dieter

AU - Leuschner, Ivo

AU - Ladanyi, Marc

AU - Argani, Pedram

AU - Eble, John

AU - Struckmann, Kirsten

AU - Schraml, Peter

AU - Moch, Holger

PY - 2004/9

Y1 - 2004/9

N2 - A new WHO classification of renal cell carcinoma has been introduced in 2004. This classification includes the recently described renal cell carcinomas with the ASPL-TFE3 gene fusion and carcinomas with a PRCC-TFE3 gene fusion. Collectively, these tumors have been termed Xp11.2 or TFE3 translocation carcinomas, which primarily occur in children and young adults. To further study the characteristics of renal cell carcinoma in young patients and to determine their genetic background, 41 renal cell carcinomas of patients younger than 22 years were morphologically and genetically characterized. Loss of heterozygosity analysis of the von Hippel-Lindau gene region and screening for VHL gene mutations by direct sequencing were performed in 20 tumors. TFE3 protein overexpression, which correlates with the presence of a TFE3 gene fusion, was assessed by immunohistochemistry. Applying the new WHO classification for renal cell carcinoma, there were 6 clear cell (15%), 9 papillary (22%), 2 chromophobe, and 2 collecting duct carcinomas. Eight carcinomas showed translocation carcinoma morphology (20%). One carcinoma occurred 4 years after a neuroblastoma. Thirteen tumors could not be assigned to types specified by the new WHO classification: 10 were grouped as unclassified (24%), including a unique renal cell carcinoma with prominently vacuolated cytoplasm and WT1 expression. Three carcinomas occurred in combination with nephroblastoma. Molecular analysis revealed deletions at 3p25-26 in one translocation carcinoma, one chromophobe renal cell carcinoma, and one papillary renal cell carcinoma. There were no VHL mutations. Nuclear TFE3 overexpression was detected in 6 renal cell carcinomas, all of which showed areas with voluminous cytoplasm and foci of papillary architecture, consistent with a translocation carcinoma phenotype. The large proportion of TFE3 "translocation" carcinomas and "unclassified" carcinomas in the first two decades of life demonstrates that renal cell carcinomas in young patients contain genetically and phenotypically distinct tumors with further potential for novel renal cell carcinoma subtypes. The far lower frequency of clear cell carcinomas and VHL alterations compared with adults suggests that renal cell carcinomas in young patients have a unique genetic background.

AB - A new WHO classification of renal cell carcinoma has been introduced in 2004. This classification includes the recently described renal cell carcinomas with the ASPL-TFE3 gene fusion and carcinomas with a PRCC-TFE3 gene fusion. Collectively, these tumors have been termed Xp11.2 or TFE3 translocation carcinomas, which primarily occur in children and young adults. To further study the characteristics of renal cell carcinoma in young patients and to determine their genetic background, 41 renal cell carcinomas of patients younger than 22 years were morphologically and genetically characterized. Loss of heterozygosity analysis of the von Hippel-Lindau gene region and screening for VHL gene mutations by direct sequencing were performed in 20 tumors. TFE3 protein overexpression, which correlates with the presence of a TFE3 gene fusion, was assessed by immunohistochemistry. Applying the new WHO classification for renal cell carcinoma, there were 6 clear cell (15%), 9 papillary (22%), 2 chromophobe, and 2 collecting duct carcinomas. Eight carcinomas showed translocation carcinoma morphology (20%). One carcinoma occurred 4 years after a neuroblastoma. Thirteen tumors could not be assigned to types specified by the new WHO classification: 10 were grouped as unclassified (24%), including a unique renal cell carcinoma with prominently vacuolated cytoplasm and WT1 expression. Three carcinomas occurred in combination with nephroblastoma. Molecular analysis revealed deletions at 3p25-26 in one translocation carcinoma, one chromophobe renal cell carcinoma, and one papillary renal cell carcinoma. There were no VHL mutations. Nuclear TFE3 overexpression was detected in 6 renal cell carcinomas, all of which showed areas with voluminous cytoplasm and foci of papillary architecture, consistent with a translocation carcinoma phenotype. The large proportion of TFE3 "translocation" carcinomas and "unclassified" carcinomas in the first two decades of life demonstrates that renal cell carcinomas in young patients contain genetically and phenotypically distinct tumors with further potential for novel renal cell carcinoma subtypes. The far lower frequency of clear cell carcinomas and VHL alterations compared with adults suggests that renal cell carcinomas in young patients have a unique genetic background.

KW - Microsatellite instability

KW - Pediatric renal tumors

KW - TFE3

KW - Translocation carcinomas

KW - VHL gene

KW - Wilms tumor

UR - http://www.scopus.com/inward/record.url?scp=3442875929&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3442875929&partnerID=8YFLogxK

U2 - 10.1097/01.pas.0000131558.32412.40

DO - 10.1097/01.pas.0000131558.32412.40

M3 - Article

C2 - 15316311

AN - SCOPUS:3442875929

VL - 28

SP - 1117

EP - 1132

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 9

ER -